Join us for an important webinar in collaboration with our national partner, Slater and Gordon, as we explore mesothelioma - a rare and aggressive cancer linked to asbestos exposure.
This clinical update features key medical articles from global journals with commentary from Bronwyn Jennings, the Gynae Oncology Clinical Nurse Consultant at Mater Hospital Brisbane, Australia and Chair of CNSA's Gynaecological Oncology Specialist Practice Network.
We are thrilled to congratulate Melanie Rabbets as the recipient of the 2025 Slater and Gordon World Lung Cancer Conference Scholarship.
Thanks to the generous support of our long-standing partners at Slater and Gordon, Melanie will travel to Barcelona, Spain, to attend the 2025 World Conference on Lung Cancer (WLCC) in September.
Our friends at Slater and Gordon have received fantastic feedback and interest following their breakfast sessions at the CNSA and ICCN Congress. Want to know more?
We are pleased to congratulate our colleagues at the Clinical Oncology Society of Australia (COSA) on the launch of a landmark research report—E-Cigarettes and Cancer—which presents a qualitative risk assessment of the evidence linking e-cigarette use to cancer.
This event will explore the latest advancements in screening technologies, innovative treatment approaches, and strategies to improve outcomes for lung cancer patients.
The new National Lung Cancer Screening Program (NLCSP) is now available for eligible Australians aged 50 to 70 with a smoking history and no signs or symptoms of lung cancer.
Online form for HCP referrals or patients to request for telephone call with Lung Cancer Nurse or Lung Cancer Social Worker or information and resources
Lung Foundation Australia is excited to announce applications open 29 May 2025 to support attendance at the 2025 World Conference on Lung Cancer, which will run from September 6 to 9 in Barcelona, Spain.
